13F-HR filed by Prosight Management, LP
Prosight Management, LP filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-05-14, with 37 holding rows worth $122,124,000.
- Accession
- 0001420506-21-000690
- Filer
- CIK 1617201
- Filed
- 2021-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2021
A holdings report, 37 entries on the cover page, a total value of $122,124,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $122,124,000 with VALUE read as thousands by filing date, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PROTHENA CORP PLC SHS | G72800108 | Stock | 600,000 | $15,072,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 38,350 | $8,241,000 | thousands by filing date | |
| ENCOMPASS HEALTH CORP COM | 29261A100 | Stock | 100,000 | $8,190,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 105,828 | $7,343,000 | thousands by filing date | |
| CUE BIOPHARMA INC | 22978P106 | COM | 556,777 | $6,793,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 95,600 | $6,035,000 | thousands by filing date | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 170,352 | $6,005,000 | thousands by filing date | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 473,446 | $5,625,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 66,419 | $5,120,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 360,834 | $4,685,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 750,310 | $4,472,000 | thousands by filing date | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 291,944 | $4,213,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 195,000 | $3,806,000 | thousands by filing date | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 21,197 | $3,393,000 | thousands by filing date | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 450,165 | $2,976,000 | thousands by filing date | |
| OSCAR HEALTH INC | 687793109 | CL A | 107,086 | $2,878,000 | thousands by filing date | |
| CELLECTIS ADS | 15117K103 | COM | 137,900 | $2,787,000 | thousands by filing date | |
| INOVALON HLDGS INC | 45781D101 | COM CL A | 85,000 | $2,446,000 | thousands by filing date | |
| Medtronic Plc | G5960L103 | COM | 20,088 | $2,373,000 | thousands by filing date | |
| UnitedHealth Group Inc | 91324P102 | COM | 6,000 | $2,232,000 | thousands by filing date | |
| CARA THERAPEUTICS INC | 140755109 | COM | 100,000 | $2,171,000 | thousands by filing date | |
| METACRINE INC | 59101E103 | COM | 304,485 | $1,888,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 320,100 | $1,770,000 | thousands by filing date | |
| LHC GROUP | 50187A107 | COM | 8,783 | $1,679,000 | thousands by filing date | |
| AKUMIN INC | 01021F109 | COM | 429,061 | $1,588,000 | thousands by filing date | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 17,000 | $1,361,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 8,685 | $1,328,000 | thousands by filing date | |
| ONCORUS INC | 68236R103 | COM | 70,807 | $986,000 | thousands by filing date | |
| APTOSE BIOSCIENCES INC COM | 03835T200 | Stock | 150,000 | $896,000 | thousands by filing date | |
| ADMA BIOLOGICS INC | 000899104 | COM | 497,842 | $876,000 | thousands by filing date | |
| EXICURE INC | 30205M101 | COM | 275,848 | $601,000 | thousands by filing date | |
| SIO GENE THERAPIES INC | 829399104 | COM | 205,900 | $537,000 | thousands by filing date | |
| BAXTER INTL INC | 071813109 | COM | 5,800 | $489,000 | thousands by filing date | |
| ODONATE THERAPEUTICS INC | 676079106 | COM | 117,621 | $402,000 | thousands by filing date | |
| MORPHIC HLDG INC | 61775R105 | COM | 5,202 | $329,000 | thousands by filing date | |
| ORGANOGENESIS HOLDINGS INC | 68621F102 | COMMON STOCK | 15,232 | $278,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 56,500 | $260,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-21-000690 | this filing | 2021-05-14 | acceptance time not in the bulk data set |